688 related articles for article (PubMed ID: 1847724)
21. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
[TBL] [Abstract][Full Text] [Related]
22. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Linsley PS
J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
[TBL] [Abstract][Full Text] [Related]
23. Host T-cell primary allosensitization to MHC class-I- and class-II-expressing human cardiac myocytes requires the presence of a second signal.
Ansari AA; Wang YC; Kanter K; Villinger F; Mayne A; Sell KW; Herskowitz A
Hum Immunol; 1993 Jun; 37(2):108-18. PubMed ID: 8226137
[TBL] [Abstract][Full Text] [Related]
24. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.
Turka LA; Linsley PS; Lin H; Brady W; Leiden JM; Wei RQ; Gibson ML; Zheng XG; Myrdal S; Gordon D
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):11102-5. PubMed ID: 1332070
[TBL] [Abstract][Full Text] [Related]
25. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
Hirokawa M; Gray JD; Takahashi T; Horwitz DA
J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
[TBL] [Abstract][Full Text] [Related]
26. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
[TBL] [Abstract][Full Text] [Related]
27. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
[TBL] [Abstract][Full Text] [Related]
28. Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
Clements JL; Winslow G; Donahue C; Cooper SM; Allison JP; Budd RC
Int Immunol; 1993 Nov; 5(11):1451-60. PubMed ID: 7903158
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Hoskin DW
J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
[TBL] [Abstract][Full Text] [Related]
30. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
Behar SM; Porcelli SA; Beckman EM; Brenner MB
J Exp Med; 1995 Dec; 182(6):2007-18. PubMed ID: 7500046
[TBL] [Abstract][Full Text] [Related]
31. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions.
Savage CO; Hughes CC; McIntyre BW; Picard JK; Pober JS
Transplantation; 1993 Jul; 56(1):128-34. PubMed ID: 7687392
[TBL] [Abstract][Full Text] [Related]
32. CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
Harding FA; Allison JP
J Exp Med; 1993 Jun; 177(6):1791-6. PubMed ID: 7684435
[TBL] [Abstract][Full Text] [Related]
33. In vitro analysis of CD40-CD154 and CD28-CD80/86 interactions in the primary T-cell response to allogeneic "nonprofessional" antigen presenting cells.
Laning JC; Deluca JE; Isaacs And CM; Hardin-Young J
Transplantation; 2001 May; 71(10):1467-74. PubMed ID: 11391237
[TBL] [Abstract][Full Text] [Related]
34. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
[TBL] [Abstract][Full Text] [Related]
35. A co-stimulatory role for CD28 in the activation of CD4+ T lymphocytes by staphylococcal enterotoxin B.
Goldbach-Mansky R; King PD; Taylor AP; Dupont B
Int Immunol; 1992 Dec; 4(12):1351-60. PubMed ID: 1363054
[TBL] [Abstract][Full Text] [Related]
36. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.
Wilson JL; Cunningham AC; Kirby JA
Immunology; 1995 Nov; 86(3):325-30. PubMed ID: 8550066
[TBL] [Abstract][Full Text] [Related]
37. The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor.
Freeman GJ; Cardoso AA; Boussiotis VA; Anumanthan A; Groves RW; Kupper TS; Clark EA; Nadler LM
J Immunol; 1998 Sep; 161(6):2708-15. PubMed ID: 9743327
[TBL] [Abstract][Full Text] [Related]
38. Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation.
Van Gool SW; Ceuppens JL; Walter H; de Boer M
Blood; 1994 Jan; 83(1):176-83. PubMed ID: 7506079
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
[TBL] [Abstract][Full Text] [Related]
40. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
